The "Fungal Multiplex Detection and Differentiation for Cryptococcus, Stachybotrys, Histoplasma RNA Detection Qualitative Test" is a sophisticated diagnostic assay offered by DNA Labs UAE, designed to accurately identify and differentiate between RNA of three significant fungal pathogens: Cryptococcus, Stachybotrys, and Histoplasma. This qualitative test utilizes advanced molecular techniques to detect the presence of these fungi, which are responsible for causing severe respiratory and systemic infections, particularly in immunocompromised individuals. The test is priced at 2550 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high sensitivity and specificity. By providing rapid and precise results, this test plays a crucial role in the early diagnosis and management of fungal infections, facilitating appropriate treatment decisions and improving patient outcomes.
The Complement-Dependent Cytotoxicity (CDC) Crossmatch Test is a critical diagnostic procedure used in the field of transplantation immunology to assess the compatibility between a donor's organ and a potential recipient. This test plays a pivotal role in preventing organ transplant rejection by identifying the presence of pre-existing antibodies in the recipient's serum that might react against the donor's antigens. By adding the recipient's serum to the donor's lymphocytes in the presence of complement, the test can detect whether the antibodies lead to cell lysis, indicating a positive result and a higher risk of transplant rejection.
Performed at DNA Labs UAE, a leading facility known for its state-of-the-art technology and expertise in genetic and immunological testing, the CDC Crossmatch Test is conducted with the utmost precision and care. The test cost is set at 2550 AED, reflecting the comprehensive approach and advanced techniques employed to ensure accurate and reliable results. This investment is crucial for the success of organ transplants, significantly impacting patient outcomes by guiding the selection of compatible donors and minimizing the risk of transplant rejection.
The Influenza Like Illness (ILI) SARS-CoV-2 Panel Test is a comprehensive diagnostic tool available at DNA Labs UAE, designed to accurately identify the presence of SARS-CoV-2—the virus responsible for COVID-19—as well as other pathogens that cause influenza-like symptoms. Priced at 2000 AED, this panel test is an essential resource in the clinical assessment of patients presenting with symptoms such as fever, cough, sore throat, and body aches, which are common to a variety of respiratory infections.
By simultaneously testing for multiple viruses, the ILI SARS-CoV-2 Panel Test enables healthcare providers to swiftly differentiate between SARS-CoV-2 and other respiratory viruses, facilitating timely and appropriate treatment decisions. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test employs the latest in molecular diagnostic technology to ensure high sensitivity and specificity, offering patients and healthcare professionals alike peace of mind through accurate and reliable results.
Given the overlapping symptoms of many respiratory infections, the ability to accurately distinguish between them, especially in the context of the ongoing COVID-19 pandemic, is invaluable. The ILI SARS-CoV-2 Panel Test represents a significant advancement in the management and containment of respiratory infectious diseases, contributing to improved patient outcomes and public health.
The "JAK2 V617F, CALR, and MPL Mutation Detection Profile Test" is a comprehensive diagnostic assessment designed to detect specific genetic mutations associated with myeloproliferative neoplasms (MPNs), a group of blood cancers that affect the production of blood cells in the bone marrow. These mutations include the JAK2 V617F mutation, mutations in the CALR gene, and mutations in the MPL gene. Each of these genetic alterations plays a significant role in the pathogenesis of MPNs, influencing both the disease course and treatment response.
Administered at DNA Labs UAE, a reputable genetic testing facility, this test is crucial for accurately diagnosing MPNs, including polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Early and precise identification of these mutations allows for tailored treatment strategies, improving patient outcomes.
The test involves collecting a blood sample from the patient, which is then analyzed using advanced molecular techniques to identify the presence of the JAK2 V617F, CALR, and MPL mutations. The results of this test can significantly impact the management and therapeutic approach for individuals diagnosed with MPNs.
The cost of the "JAK2 V617F, CALR, and MPL Mutation Detection Profile Test" at DNA Labs UAE is 2690 AED. Given the complexity of the test and the invaluable insights it provides into the genetic underpinnings of MPNs, it represents a critical investment in the health and well-being of patients facing these challenging conditions.
The Vasoactive Intestinal Polypeptide (VIP) Test is a specialized diagnostic procedure designed to measure the levels of VIP in the blood. VIP is a neuropeptide that plays a crucial role in various bodily functions, including the regulation of smooth muscle activity, secretion of pancreatic juices, and control of water and electrolyte balance in the intestines. Abnormal levels of VIP can be indicative of certain health conditions, such as VIPomas (tumors that produce VIP) and other related disorders.
The test involves a simple blood draw from the patient, after which the sample is analyzed to determine the concentration of VIP. It's a critical tool for healthcare providers in diagnosing and managing conditions associated with abnormal VIP levels, ensuring timely and appropriate treatment for affected individuals.
At DNA Labs UAE, the Vasoactive Intestinal Polypeptide (VIP) Test is offered at a cost of 2690 AED. DNA Labs UAE is renowned for its state-of-the-art facilities and commitment to providing accurate and reliable diagnostic services. By choosing DNA Labs UAE for the VIP Test, patients can expect professional service, precise results, and comprehensive support throughout the testing process.
The "Cultured AFB Antitubercular DST Rapid 10 Drugs Panel Test" is an advanced diagnostic procedure offered by DNA Labs UAE, designed to detect and determine the drug susceptibility of Mycobacterium tuberculosis, the bacterium responsible for tuberculosis (TB). This comprehensive test evaluates the bacterium's resistance against a panel of 10 different antitubercular drugs, providing critical information for the formulation of an effective treatment plan. The test is particularly valuable in regions with high rates of drug-resistant TB, enabling healthcare providers to tailor therapy to the individual patient's needs and reduce the spread of resistant strains. Priced at 2690 AED, this test represents a significant investment in accurate and rapid TB management, leveraging cutting-edge laboratory techniques to deliver results with potentially life-saving implications.
Prenatal diagnostic screening through karyotyping is a critical test conducted to detect chromosomal abnormalities in a fetus. This procedure involves analyzing the chromosomal composition of cells, usually obtained via amniocentesis or chorionic villus sampling, to identify any genetic disorders that may affect the baby's health. At DNA Labs UAE, this sophisticated test is offered at a cost of 2400 AED. The karyotyping test provides expectant parents with crucial information about their unborn child's genetic health, enabling early detection of conditions such as Down syndrome, Edwards syndrome, or Patau syndrome, among others. By opting for this test at DNA Labs UAE, parents can make informed decisions about their pregnancy with the guidance of healthcare professionals.
The QF PCR Panel 131821XY and Karyotyping Test is a comprehensive diagnostic tool used to detect genetic abnormalities and chromosomal disorders. Conducted at DNA Labs UAE, this test combines the precision of Quantitative Fluorescence Polymerase Chain Reaction (QF-PCR) with the broad scope of karyotyping analysis to offer a detailed examination of an individual's genetic makeup.
The QF-PCR component specifically targets and amplifies small sections of DNA to detect chromosomal anomalies related to common conditions such as Down syndrome, Edwards syndrome, and Patau syndrome, as well as abnormalities in the sex chromosomes (XY). This technique is highly sensitive and can deliver results quickly, making it an invaluable tool for early diagnosis.
Karyotyping, on the other hand, provides a broader view by examining the entire set of chromosomes in a cell. This method can identify structural abnormalities, such as deletions, duplications, inversions, and translocations, that might be missed by more targeted approaches. It is particularly useful for diagnosing complex genetic disorders and for guiding treatment and management decisions.
The test is available at DNA Labs UAE, a leading facility in genetic testing, for a cost of 2400 AED. Given its comprehensive nature, the QF PCR Panel 131821XY and Karyotyping Test is an excellent choice for individuals seeking a thorough genetic analysis, whether for themselves or for their children. The combination of these two methods enhances the accuracy of diagnosis and provides a solid foundation for understanding and addressing genetic conditions.
The "Adenovirus, Boca Virus, Metapneumovirus, and RSV Detection and Differentiation RNA Detection Qualitative Test" is a sophisticated diagnostic assay designed to accurately identify and differentiate between four common respiratory viruses: Adenovirus, Human Bocavirus (HBoV), Human Metapneumovirus (hMPV), and Respiratory Syncytial Virus (RSV). Utilizing advanced RNA detection methodologies, this qualitative test can determine the presence of these viruses in a patient's sample, providing crucial information for the diagnosis and management of respiratory infections.
Performed at DNA Labs UAE, a leading facility in molecular diagnostics, this test leverages state-of-the-art technology to ensure high sensitivity and specificity. It is particularly valuable in clinical settings where accurate virus identification can guide treatment decisions and infection control measures. The cost of the test is set at 2400 AED, reflecting the comprehensive nature of the assay and the sophisticated technology involved.
This test is essential for patients presenting with symptoms of respiratory infections, especially in cases where conventional diagnostic methods fail to pinpoint the causative agent. By offering a detailed viral analysis, the test aids healthcare providers in delivering targeted care, potentially improving patient outcomes.
The "Bordetella Multiplex Bordetella Pertussis Legionella Pneumophila Klebsiella Pneumonia and Mycoplasma Pneumonia Detection and Differentiation RNA Detection Qualitative Test" is a comprehensive diagnostic assay conducted by DNA Labs UAE. This advanced molecular test is designed to simultaneously detect and differentiate between RNA of several pathogens responsible for serious respiratory infections. The pathogens covered in this test include Bordetella pertussis, which causes whooping cough; Legionella pneumophila, responsible for Legionnaires' disease; Klebsiella pneumoniae, a common cause of pneumonia; and Mycoplasma pneumoniae, which causes atypical pneumonia.
Utilizing sophisticated RNA detection techniques, this qualitative test provides a highly accurate diagnosis, enabling healthcare providers to tailor the most effective treatment strategies for patients. The test is particularly valuable in clinical settings where rapid identification of the causative agent is crucial for patient management and in preventing the spread of these infections.
The cost of the test is 2720 AED, reflecting the advanced technology and the comprehensive nature of the diagnostics provided. Conducted at DNA Labs UAE, a facility known for its cutting-edge diagnostic services, this test represents a significant advancement in the field of infectious disease diagnosis, offering a high level of precision and reliability for healthcare practitioners and patients alike.
